首页|期刊导航|南方医科大学学报|重骨颗粒通过调控Nrf2通路改善膝骨关节炎肝肾亏虚证患者的软骨损伤

重骨颗粒通过调控Nrf2通路改善膝骨关节炎肝肾亏虚证患者的软骨损伤OA

Chonggu Granules attenuate cartilage injury in knee osteoarthritis patients with liver-kidney deficiency syndrome by regulating the Nrf2 pathway

中文摘要英文摘要

目的 基于网络药理学、分子对接与临床验证,探讨重骨颗粒通过调控软骨细胞铁死亡治疗膝骨关节炎(KOA)的潜在机制.方法 通过TCMSP、GeneCards、OMIM及TTD数据库筛选重骨颗粒活性成分靶点及KOA、软骨细胞铁死亡相关靶点,取三者交集获取潜在作用靶点.利用Cytoscape 3.10.4构建"复方-成分-疾病-靶点"网络及蛋白质互作网络,筛选关键活性成分与核心靶点并进行分子对接验证.临床研究纳入62例KOA患者(随机分为观察组与对照组各31例)及20名健康受试者.对照组口服盐酸氨基葡萄糖片,观察组联合重骨颗粒治疗,疗程12周.采用ELISA检测各组血清中软骨损伤指标(MMP-13、CTX-II、COMP)及铁死亡相关指标(GPX4、ACSL4、4-HNE、Fe²+)水平,Real-time PCR检测Keap1、Nrf2、SLC7A11、HO-1、GPX4 mRNA表达.结果 筛选出重骨颗粒关键活性成分4种(槲皮素、圣草酚、山奈酚、黄芩素)及核心靶点5个(AKT1、TP53、IL-6、JUN、Nrf2).富集分析提示其作用涉及癌症通路、AGE-RAGE及NFE2L2(Nrf2)等信号通路.分子对接显示活性成分与靶点结合良好,其中NFE2L2结合活性最佳.临床试验表明,重骨颗粒可显著上调Nrf2、SLC7A11、HO-1、GPX4 mRNA表达(P<0.05),下调Keap1表达(P<0.05),并降低血清MMP-13、CTX-II、COMP、ACSL4、4-HNE、Fe²+水平(P<0.05),提高GPX4含量(P<0.05).结论 重骨颗粒通过槲皮素、圣草酚等关键活性成分作用于NFE2L2等靶点,激活Nrf2通路,调控铁死亡进程,从而减轻KOA软骨细胞损伤,体现多成分-多靶点-多通路的协同作用机制.

Objective To explore the mechanism mediating the ameliorative effect of Chonggu Granules on cartilage injury in knee osteoarthritis(KOA).Methods Bioinformatics approaches were used for analyzing the active ingredients of Chonggu Granules,their potential targets,the KOA-and ferroptosis-related genes,and their intersection genes.A compound-ingredient-disease-target network and the protein-protein interaction(PPI)network were constructed to identify the key active ingredients and core targets,which were verified by molecular docking studies.In the clinical trial,62 KOA patients were randomly assigned into the observation group and control group(n=31)for treatment with glucosamine hydrochloride tablets and additional Chonggu Granules for 12 weeks,respectively,with 20 healthy participants serving as the healthy control group.Serum levels of cartilage injury markers(MMP-13,CTX-II,and COMP)and ferroptosis-related indices(GPX4,ACSL4,4-HNE,and Fe2+)were measured using ELISA,and expressions of Keap1,Nrf2,SLC7A11,HO-1,and GPX4 mRNAs were determined with real-time PCR.Results Four key active ingredients(quercetin,eupatilin,kaempferol,and wogonin)of Chonggu Granules and 5 core targets(AKT1,TP53,IL-6,JUN,and Nrf2)were identified,which were involved in cancer,AGE-RAGE signaling,and the NFE2L2(Nrf2)signaling pathways.Molecular docking showed strong binding between the active compounds and their targets,with NFE2L2 exhibiting the highest binding affinity.Compared with the control patients,KOA patients treated with Chonggu Granules showed significantly upregulated Nrf2,SLC7A11,HO-1,and GPX4 mRNA expressions(P<0.05),downregulated Keap1 expression(P<0.05),reduced serum levels of MMP-13,CTX-II,COMP,ACSL4,4-HNE,and Fe2+(P<0.05),and increased GPX4 level(P<0.05).Conclusion Chonggu Granules alleviate KOA through its key active ingredients quercetin and eupatilin,which activate the Nrf2 signaling pathway to modulate ferroptosis by targeting NFE2L2 and other therapeutic targets,suggesting a multi-component,multi-target,and multi-pathway synergistic mechanism for ameliorating chondrocyte injury in KOA.

程园园;黄传兵;张娟;朱雅文;钱爱

安徽中医药大学第一临床医学院,安徽 合肥 230000安徽中医药大学第一附属医院风湿免疫科,安徽 合肥 230031||新安医学教育部重点实验室,安徽 合肥 230038安徽中医药大学第一附属医院神经内科,安徽 合肥 230031安徽中医药大学第一临床医学院,安徽 合肥 230000安徽中医药大学第一临床医学院,安徽 合肥 230000

膝骨关节炎重骨颗粒网络药理学软骨细胞铁死亡

knee osteoarthritisChonggu Granulesnetwork pharmacologychondrocytesferroptosis

《南方医科大学学报》 2026 (5)

1028-1038,11

国家自然科学基金(82104782)大健康研究院新安医学与中医药现代化研究所专项资金资助(2023CXMMTCM004)安徽省临床医学研究转化专项项目(202304295107020114,202304295107020115)安徽省教育厅研究生创新创业实践项目(2023cxcysj111)Supported by National Natural Science Foundation of China(82104782).

10.12122/j.issn.1673-4254.2026.05.06

评论